Los fármacos de acción prolongada podrían revolucionar el tratamiento de VIH
Nuevos tratamientos en desarrollo, que incluyen píldoras de una vez [...]
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
New regimens in development, including once-weekly pills and semiannual shots, [...]
David Egilman, Doctor Who Took On Drug Companies, Dies at 71
His testimony as an expert witness in some 600 trials [...]
La nueva realidad mundial del dengue exige encontrar una mejor vacuna
Los gobiernos de América Latina han confirmado más de 3,5 [...]
The Push for a Better Dengue Vaccine Grows More Urgent
A public research institute in Brazil has proved a new [...]
J&J, Merck and Bristol Myers Squibb CEOs Testify at Senate Hearing on Drug Prices
The top executives of three major companies appeared before a [...]
El caso de Singulair, un medicamento para el asma que provocó angustia
Un medicamento contra el asma, que ya se consigue como [...]
F.D.A. Warned of Mental Side Effects from Asthma Drug, Singulair. Few Were Told.
Singulair, now a generic, is still used by millions of [...]
Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations
The government will soon announce the first 10 medications that [...]
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it [...]